Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Feb 27, 2024

Dr. Marc Conant, Chief Medical Officer at Addimmune, has been working on HIV/AIDS for over 40 years and highlights the progress that has been made in developing effective HIV drugs. The mission at Addimmune is to develop a functional cure for HIV by modifying the patient's cells to enhance the immune system's ability to control the virus. This autologous cell therapy approach has been used successfully in treating leukemia and lymphoma and shows promise in suppressing HIV.  

Marc explains, "I started caring for AIDS patients in 1981, and it wasn't until AGT came along in 1988, '87, '88, that we even had anything that would work. Up until that time, everyone who contracted the disease died. HIV kills about 94% of people who are infected. What we saw early on with AGT was a drug that suppressed the virus, and then we found the next drug that suppressed the virus, and then the next one, and now we have close to 40 different drugs that can suppress the virus."

"Now, there's been even a step beyond that. You all probably see on your television every night injections that can be given once every two months, and sure enough, that works and works great, so instead of taking a pill every day, you only need to see a doctor six times a year. Every two months, you go in for two injections, and you're good for two months. And compliance is better. Patients remember to take their drug because it's given to them in an injection."

"All of that, though, still requires putting in a drug. We're hoping to take the patient's cells, modify them, put them back in the patient, and have a one-and-done treatment for the rest of his life with these modified cells, which helps the patient's immune system control the virus. The virus will be suppressed. The patient will not need to take more medication. The patient will not have side effects. The patient doesn't have to remember to take his drugs, and we've got a functional cure that will control the disease."

#Addimmune #HIV #AIDS #HIVAIDS #CARTCell #CellTherapy #FunctionalCure #HIVTreatment #AutologousCellTherapy 

Addimmune.com

Listen to the podcast here

Addimmune